Cervical pregnancy (CP) is a rare form of ectopic pregnancy. Implantation of the pregnancy occurs in the lining of the endocervical canal. The incidence ranges from 1 in 1000 up to 1 in 18,000 and accounts for less than 1% of ectopic pregnancies. 1 The etiology of CP is unknown, although some theories do exist. It is extremely difficult to manage and could be life threatening when catastrophic hemorrhaging occurs. With the implementation of highresolution sonography, CP can be diagnosed early, and conservative, fertility-preserving treatments can be administered.
machine with both the AB2-7 and RIC5-9H probes (Waukesha, Wisconsin). Sonography revealed an empty uterus and a viable 6-week, 6-day embryo within the endocervical canal ( Figs. 1-3) . The cervical os was closed. The left ovary contained a corpus luteum cyst. The patient was admitted to the hospital for treatment immediately. After discussion of the treatment options, risks, and benefits, the patient elected methotrexate (MTX) therapy as a chemotherapeutic option to end the viability of the pregnancy. The patient underwent three doses of intramuscular MTX injections totaling 150 mg. It was given every other day with intervening doses of leucovorin. Prior to the fourth dose, the patient's liver function tests were elevated, and the therapy was halted. Despite each dose of MTX, the beta hCG levels continued to increase. Pelvic sonography was repeated and revealed a viable cervical pregnancy. The physicians discussed two options with the patient: a total abdominal hysterectomy or intralesional injection of MTX with potassium chloride. The second option was elected by the patient. Transcervical fetal injection was performed with potassium chloride followed by injection of MTX into the gestational sac. Prophylactic uterine artery embolization was performed by interventional radiology. The patient was stable for 24 hours after the procedure and was then discharged.
Discussion
Cervical pregnancy, a rare and potentially catastrophic form of ectopic pregnancy, results from the implantation of the blastocyst within the cervical canal. The exact etiology is unknown, although some theories do exist. One theory is that the fertilized ovum rapidly transports into the endocervical canal because of an unreceptive endometrium or before it is capable of implantation. It has also been suggested that in the same way a woman who has had a previous C-section is at higher risk for placenta previa, placenta accreta, and percreta, the same pathophysiological mechanism happens in cases of CP. Another theory involves patients who have had previous dilatation and curettage (D & C). Although the exact pathophysiologic mechanism concerning a D & C is not known, cervical trauma brought on by rapid dilatation and sharp curettage is suspected to be the etiological factor involved. Another theory is an association with Asherman's syndrome due to the uterine surgery that sometimes takes place with this condition. It has also been seen in cases of in vitro fertilization (IVF). Cervical pregnancy occurs in 0.1% of IVF pregnancies and accounts for 3.7% of IVF ectopic pregnancies. However, these patients have other multiple risk factors too, such as a history of cervical instrumentation. The next theory involves a primary embryo anomaly. Upon karotyping of tubal pregnancies, a 33% to 76.9% rate of chromosomal abnormalities was revealed. This finding suggests that abnormal embryogenesis may greatly contribute to the incidence of ectopic implantation. A cervical pregnancy can be idiopathic. It has occurred in patients with no apparent risk factors. 2 The most common clinical symptom is vaginal bleeding. Other symptoms include lower abdominal cramps or pain. It is rare to have pain without bleeding. Urinary difficulties have been reported when the pregnancy was more advanced. The diagnosis of cervical pregnancy relies mainly on sonographic findings. Magnetic resonance imaging can be helpful in complicated or unusual cases. The best sonographic results can be obtained using both transabdominal and endocavity sonography. The sonographic criteria consist of a closed internal cervical os, intracervical location of a well-formed gestational sac that is surrounded by an echogenic rim, and trophoblastic invasion of the endocervical tissue. 3 Another criterion is absence of the sliding sign. In a miscarriage, when pressure is placed against the cervix using the probe, the gestational sac slides against the endocervical canal. This does not occur in an implanted cervical pregnancy. Some additional signs include visualization of an embryo or fetus in the cervix area, hyperechogenic endometrium, empty uterine cavity, and location of the gestational sac below the level of the uterine arteries. Peritrophoblastic blood flow can be documented using color Doppler. 4 A differential diagnosis of an intrauterine pregnancy in the process of aborting or a caesarean or hysterotomy scar pregnancy should be considered. An aborting pregnancy is the likely diagnosis if there are some products of conception or a blood clot is seen in the intrauterine cavity, a large uterine cavity compared to the cervix is seen, an open internal cervical os is visualized, there is a flattened gestational sac with no echogenic rim and no embryo or an embryo without a heartbeat, or there is no sign of trophoblastic invasion of the cervical stroma. If the diagnosis is uncertain, a repeat sonographic procedure the next day can be done to see if the sac has moved. This would suggest a cervical abortion. Caesarean or hysterotomy scar pregnancy would be considered if the uterine cavity and endocervical canal is empty, and the gestational sac is in the anterior lower uterine segment. 3 A cervical pregnancy can be treated either medically or surgically. Medical treatment involves a single or multidose systemic MTX administration. A multidose regimen has become first-line treatment when fetal cardiac activity is present. 4 Another option is local intrasac injection of potassium chloride or MTX. At times, a combination of these therapies is performed. Surgical therapy is also an option. Traditionally, a D & C is performed with a hysterectomy if there is hemorrhaging that cannot be controlled. A conservative surgical option is dilation and evacuation (D & E). The main complication is a high occurrence of severe bleeding. This can be reduced by preoperatively ligating the cervical branches of the uterine arteries transvaginally, angiographic uterine artery embolization, cerclage, or intracervical vasopressin injection. 2 Another conservative treatment option has evolved after a study was performed in Taiwan by Kung et al 5 at Chang Gung Memorial Hospital. They were successful in using a combination of laparoscopy-assisted uterine artery ligation and hysteroscopic endocervical resection. Although MTX therapy has a 91% success rate, it also carries a risk of MTX-related side effects: a mean duration of 53 days until hCG resolution, the need for additional surgical procedures in 34% of cases, and a long time for the return of menstruation. In their study, there was successful preservation of the uterus with no other surgical therapy required and commencement of menstruation at a mean of two months. Uterine artery embolization is sometimes used prior to the evacuation of the pregnancy to prevent hemorrhaging. This approach has been successful in avoiding a laparotomy or hysterectomy. It can also be used to control hemorrhaging postoperatively or along with medical therapy. 3 Subsequent reproduction is possible in patients who have had a prior CP. An eight-month follow-up is suggested to ensure functional recovery of the cervix. 6
Conclusion
Cervical pregnancy can be a life-threatening issue. Early diagnosis with transabdominal and endocavity sonography is very important in the conservative management of a cervical pregnancy. With early diagnosis and treatment, future fertility can be preserved.
